![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 3, 1587-1593, January 21, 2000
From the Glucose stimulation of pancreatic Stimulation of insulin secretion by glucose involves a rise in the
cytoplasmic concentration of Ca2+
([Ca2+]i)1
in Glucose metabolism in Many Animals--
mGPDH expression and activity in islets were
measured in Tokyo. To study the oscillatory behavior of the islets,
female wild-type (mGPDH+/+) and knockout
(mGPDH Analysis of mGPDH Expression by RT-PCR, Western Blot, and
Enzymatic Activity--
Pancreatic islets were isolated (30) from
mGPDH+/+, +/ Preparations Used to Study the Oscillatory Behavior of Measurements of Insulin Secretion,
[Ca2+]i and NAD(P)H--
The system has
previously been described (23, 32), and the control medium was the same
as that used for islet isolation. When the concentration of KCl was
raised to 30 mM, that of NaCl was reduced to 94.8 mM. Cultured islets were loaded with fura-PE3 during 2 h of incubation at 37 °C in control medium containing 2 µM fura-PE3 acetoxymethyl ester. After loading, one islet
was transferred into a 110-µl perifusion chamber with a bottom made of a glass coverslip and mounted on the stage of a microscope. The
islet was held in place by gentle suction with a micropipette. The
preparation was perifused at a flow rate of 1.8 ml/min and the medium
was collected, in fractions of 30 s, just downstream of the islet.
The temperature within the chamber was 37 °C. The [Ca2+]i was measured by dual wavelength (340 and
380 nM) excitation spectrofluorimetry, using a CCD camera
to capture images (510 nM) at 2.4-s intervals. From the
ratio of the fluorescence at 340 and 380 nm, the concentration of
[Ca2+]i was calculated by comparison with a
calibration curve (4). Insulin was measured, in duplicates, in 400-µl
aliquots of the effluent fractions. The characteristics of the
radioimmunoassay, using rat insulin as a standard, have previously been
described in detail (32). The insulin content of the islets was
determined after extraction in acid ethanol (34). It was similar in
wild-type (112 ± 9 ng/islet) and mGPDH
For the experiments in which only [Ca2+]i was
measured, 2-3 islets loaded with fura-PE3 were studied simultaneously in a larger chamber (~1 ml) perifused at a flow rate of 1.8 ml/min. When [Ca2+]i was measured in clusters of islets
cells, a coverslip with attached cells was first incubated in the
medium containing fura-PE3/AM before being transferred into the
perifusion chamber of which it formed the bottom. At the end of the
experiment, the perifusion was stopped and the chamber filled with
control solution containing 1 µM bisbenzimide. After 30 min, the preparation was excited at 365 nm and the number of cells in
the studied cluster was determined by counting the fluorescent nuclei
(at 510 nm) (33). The size of the studied clusters was similar for
wild-type (14 ± 1 cells) and mGPDH
The same experimental setup was used to measure the reduced forms of
NAD and NADP, referred to as NAD(P)H. The islets were excited at 360 nm
and the emitted fluorescence was filtered at 470 nm (4). The changes in
fluorescence were expressed as a percentage of basal values within the
same islet.
Measurement of Presentation of Results--
All experiments have been performed
with 1-3 islets from four to six different wild-type and
mGPDH mGPDH Expression and Activity in Islets--
Reverse
transcriptase-PCR analysis showed that mGPDH mRNA was not expressed
in mGPDH Glucose-induced [Ca2+]i Changes in
Clusters of Islet Cells--
In the presence of a non-stimulatory
concentration of glucose (3 mM),
[Ca2+]i was low and stable (Fig.
2, upper panels). Raising the
glucose concentration to 15 mM first induced a small drop in [Ca2+]i, that was rapidly followed by a marked
increase in three phases: a long first phase, followed by a partial and
progressive decrease with rapid oscillations, and eventually by large
and slow oscillations. These changes were essentially similar in islet cell clusters from wild-type and mGPDH
The characteristics of [Ca2+]i oscillations
occurring during steady state glucose stimulation are illustrated by
the lower panels of Fig. 2. These oscillations often
displayed a mixed pattern of small and fast transients superimposed on
slower but larger ones (Fig. 2, B and E). In
other cases only the slow oscillations were detected (Fig. 2,
C and F). In no preparation continuously stimulated with 15 mM glucose were fast oscillations
observed in the absence of slow ones. No difference could be identified in the appearance of the [Ca2+]i oscillations in
clusters from wild-type and mGPDH Glucose- and Aminooxyacetate-induced
[Ca2+]i Changes in Intact Islets--
When
islets were stimulated with 15 mM glucose,
[Ca2+]i initially decreased, then increased
markedly and started to oscillate (Fig.
3). These oscillations were sometimes
rapid (several per min) during the whole period of stimulation (not
shown), became slower after a few minutes (Fig. 3, A and
C), or were slow immediately after the first peak (not
shown). Again these patterns were seen in both wild-type and
mGPDH
Glucose-induced [Ca2+]i oscillations were
characterized further in experiments during which the islets were
continuously stimulated with 12 mM glucose (Fig.
4). Two types of patterns were observed
in wild-type islets: large and slow oscillations usually superimposed
with smaller and faster ones (mixed pattern) (85%) (Fig.
4B) and fast oscillations only (15%) (Fig. 4A).
The same patterns were observed in mGPDH
Fig. 4 also compares the effects of 1 mM AOA in both types
of islets. A small and progressive decrease in the frequency of [Ca2+]i oscillations was observed in wild-type
islets (Fig. 4B). In mGPDH Glucose- and Aminooxyacetate-induced Changes in
After about 5 min, AOA (5 mM) abolished the electrical
activity induced by 12 mM glucose and repolarized the Correlations between [Ca2+]i and Insulin
Secretion Changes--
In a first series of experiments, single
wild-type and mGPDH
In a second series of experiments, single islets were stimulated by 3 pulses (2.5 min) and a more sustained application (25 min) of 20 mM glucose in a control medium, without or with AOA. The
upper panels of Fig. 7
illustrate individual responses, and the middle panels show
mean responses. In wild-type islets, each pulse of high glucose induced
a large peak of [Ca2+]i accompanied by a peak of
insulin secretion. The sustained stimulation caused an initial peak of
[Ca2+]i followed by rapid oscillations, and a
biphasic secretion of insulin (Fig. 7A). After the large
first phase, the secretion rate dropped to lower values, which is
typical for the mouse (37, 38). Fluctuations of secretion were usually
found to follow the slow trends behind the fast
[Ca2+]i transients, but no regular oscillations
occurred. With collections every 30 s, the time resolution of the
system is insufficient to monitor fast oscillations of secretion.
Several aspects of the responses of wild-type islets were altered when
the experiments were performed in the presence of 5 mM AOA
throughout (compare the middle and lower panels
of Fig. 7, A and B). The rise in
[Ca2+]i evoked by 20 mM glucose was
clearly delayed, reaching a maximum only at the end of the 2.5-min
glucose pulses, thus resulting in shorter [Ca2+]i
oscillations. The reason of the delay is the presence of a marked drop
in [Ca2+]i immediately upon glucose stimulation,
which is best seen between 20 and 25 min (Fig. 7B, lower
panel). During the long glucose application in the presence of AOA
the elevation of [Ca2+]i displayed large
oscillations (Fig. 7B, upper panel). Again, insulin
secretion tightly followed the changes in [Ca2+]i
with delayed and shorter peaks during glucose pulses, and clear
oscillations synchronous with those of [Ca2+]i
during sustained stimulation. Total insulin secretion was about 25%
lower in the presence than absence of AOA, but this difference must be
interpreted with caution because the experiments were performed with
single islets whose individual insulin content could not always be determined.
When islets from mGPDH Effects of Glucose and [Ca2+]i on NAD(P)H
Autofluorescence--
For these experiments 100 µM
diazoxide was added to the perifusion medium to hold
[Ca2+]i at basal levels except in the presence of
30 mM KCl. Raising [Ca2+]i by high
K+ increased the NAD(P)H fluorescence at low and high
glucose, but these stimulations were much smaller than that following
the increase in glucose concentration from 3 to 15 mM (Fig.
8). The results were essentially similar
in islets from wild-type and mGPDH The mGPDH is the rate-limiting enzyme of the glycerol phosphate
shuttle which, together with the malate-aspartate shuttle, permits
reoxidation of cytosolic NADH by transferring reducing equivalents
produced during glycolysis to the mitochondria.
mGPDH is particularly abundant in pancreatic islets (16) and, in
contrast to lactate dehydrogenase, much more so in Mice with a targeted disruption of mGPDH have recently been generated
and found to be grossly normal. In particular, they were not diabetic
and their islets responded to glucose stimulation by similar increases
in the ATP/ADP ratio and insulin secretion to those observed in control
islets (21). The present study extends these findings in showing that
the glucose-induced electrical activity and
[Ca2+]i rise are quantitatively equivalent in
wild-type and mGPDH AOA, an inhibitor of various aminotransferases, is widely used to block
the malate-aspartate shuttle in islets and other tissues (17, 29, 41,
42). At the concentration of 5 mM, AOA inhibed glucose-induced insulin secretion by 50-60% in normal rat islets (17,
29). Smaller effects were observed in wild-type mouse islets.
Glucose-induced electrical activity and [Ca2+]i
rise were only attenuated and insulin secretion was slightly impaired
and delayed. If the effects of AOA solely result from an inhibition of
the malate-aspartate shuttle, which is uncertain owing to the drug
action on several aminotransferases, our results would suggest that the
malate-aspartate shuttle might exert functions that cannot be
compensated for by the glycerol phosphate shuttle. However, the minor
effects of AOA in control islets strikingly contrast with the
abrogation by the drug of the electrical, [Ca2+]i
and secretory responses to glucose in mGPDH The major goal of this study was to evaluate whether mGPDH is involved
in the oscillatory behavior of It has been proposed that a rise in In conclusion, NADH shuttles play an important role in the regulation
of insulin secretion by glucose but seem to be at least partially
redundant. Despite its [Ca2+]i dependence and
ability to display an oscillatory function in vitro, mGPDH
is not the generator of metabolic signals that might in turn induce
oscillatory biophysical and secretory responses in We are grateful to F. Knockaert for technical
aid and S. Roiseux for editorial assistance.
*
This work was supported by Grant 3.4552.98 from the Fonds de
la Recherche Scientifique Médicale (Brussels), Grant 95/00-188 from the General Direction of Scientific Research of the French Community of Belgium, the Interuniversity Poles of Attraction Program
(P4/21)-Belgian State, and Grant 10NP0201 from the Ministry of
Education, Science, Sports and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom all correspondence should be addressed: Unité
d'Endocrinologie et Métabolisme, UCL 55.30, Avenue Hippocrate
55, B-1200 Brussels, Belgium. Tel.: 32-2-764-55-29; Fax:
32-2-764-55-32; E-mail: henquin@endo.ucl.ac.be.
2
K. Eto and T. Kadowaki, unpublished data.
The abbreviations used are:
[Ca2+]i, cytoplasmic free Ca2+
concentration;
mGPDH, mitochondrial glycerol-3-phosphate dehydrogenase;
AOA, aminooxyacetate;
RT-PCR, reverse transcriptase-polymerase chain
reaction.
The Oscillatory Behavior of Pancreatic Islets from Mice with
Mitochondrial Glycerol-3-phosphate Dehydrogenase Knockout*
,
,
,
¶
Unité d'Endocrinologie et
Métabolisme, University of Louvain Faculty of Medicine, B-1200
Brussels, Belgium and the § Department of Metabolic
Diseases, Graduate School of Medicine, University of Tokyo, Bunkyo-ku,
Tokyo 113-8655, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
cells induces oscillations of the membrane potential, cytosolic
Ca2+ ([Ca2+]i), and insulin
secretion. Each of these events depends on glucose metabolism. Both
intrinsic oscillations of metabolism and repetitive activation of
mitochondrial dehydrogenases by Ca2+ have been suggested to
be decisive for this oscillatory behavior. Among these dehydrogenases,
mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH), the key
enzyme of the glycerol phosphate NADH shuttle, is activated by
cytosolic [Ca2+]i. In the present study, we
compared different types of oscillations in
cells from wild-type
and mGPDH
/
mice. In clusters of 5-30 islet cells and
in intact islets, 15 mM glucose induced an initial drop of
[Ca2+]i, followed by an increase in three phases:
a marked initial rise, a partial decrease with rapid oscillations and
eventually large and slow oscillations. These changes, in particular
the frequency of the oscillations and the magnitude of the
[Ca2+] rise, were similar in wild-type and
mGPDH
/
mice. Glucose-induced electrical activity
(oscillations of the membrane potential with bursts of action
potentials) was not altered in mGPDH
/
cells. In
single islets from either type of mouse, insulin secretion strictly
followed the changes in [Ca2+]i during imposed
oscillations induced by pulses of high K+ or glucose and
during the biphasic elevation induced by sustained stimulation with
glucose. An imposed and controlled rise of
[Ca2+]i in
cells similarly increased NAD(P)H
fluorescence in control and mGDPH
/
islets. Inhibition
of the malate-aspartate NADH shuttle with aminooxyacetate only had
minor effects in control islets but abolished the electrical,
[Ca2+]i and secretory responses in
mGPDH
/
islets. The results show that the two distinct
NADH shuttles play an important but at least partially redundant role
in glucose-induced insulin secretion. The oscillatory behavior of
cells does not depend on the functioning of mGPDH and on metabolic
oscillations that would be generated by cyclic activation of this
enzyme by Ca2+.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
cells (1, 2). This rise essentially results from the following
sequence of events: closure of ATP-sensitive K+ channels
(K+-ATP channels) in the plasma membrane, membrane
depolarization, and influx of Ca2+ through
voltage-sensitive channels (3-5). A second, important effect of
glucose is the amplification of the action of
[Ca2+]i on the exocytotic process (6-8). Both
pathways require glucose metabolism and appear to depend on a rise in
the ATP/ADP ratio (9).
cells essentially occurs through aerobic
glycolysis (10-12). An increase in the glucose concentration is
followed by an acceleration of glycolysis and an even greater stimulation of mitochondrial oxidative events, in which
Ca2+ may play an important role. Thus, the elevation of
[Ca2+]i is paralleled by an increase in
mitochondrial Ca2+ (13) that may then activate the three
Ca2+-sensitive intramitochondrial dehydrogenases and
promote ATP synthesis (14). Another feature of the
cell metabolic
organization is a low activity of lactate dehydrogenase (12, 15).
Cytosolic NADH formed during glycolysis is re-oxidized (and ATP
synthesis concomitantly stimulated) by transfer of the reducing
equivalents into mitochondria through the glycerol phosphate shuttle
and the malate-aspartate shuttle (16, 17). The rate-limiting enzyme of
the former shuttle, mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH) is located on the outer face of the mitochondrial membrane and
can be activated by increases in cytosolic
[Ca2+]i (18, 19). The importance of the NADH
shuttles for glucose-induced insulin secretion (20) has received strong support from a recent study using islets from mice with a targeted disruption of mGPDH (21).
cell responses to glucose are oscillatory. Oscillations of the
membrane potential drive oscillations of [Ca2+]i,
leading to oscillations of insulin secretion that can be amplified by
metabolic oscillations (4, 22-26). It is still unclear whether
oscillations of glucose metabolism are intrinsic and initiate the whole
chain of other pulsatile events or are entrained by the oscillations of
[Ca2+]i (27). The Ca2+ sensitivity of
mGPDH makes the enzyme a possible key site of the interplay between
glucose metabolism and [Ca2+]i oscillations.
Thus, imposed oscillations of free Ca2+ in islet
mitochondrial extracts induced oscillations of mGPDH activity (28). If
the hypothesis is correct, the oscillatory behavior of stimulus
secretion coupling should be perturbed by mGPDH defects. The present
study addressed this question with islets isolated from mGPDH knock-out
(mGPDH
/
) mice (21). We compared the oscillations of
cell membrane potential, [Ca2+]i, and insulin
secretion in islet cell clusters or single islets from wild-type
(mGPDH+/+) and mGPDH
/
mice. The impact of
an inhibition of the malate-aspartate shuttle by aminooxyacetate (AOA)
(17, 29) was also evaluated in the two groups.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
) mice were transferred from Tokyo to Brussels.
Their body weight, plasma glucose, and plasma insulin concentrations
were: 26.9 ± 0.7 g, 6.5 ± 0.2 mM, and
1.15 ± 0.14 ng/ml, respectively, for wild-type mice, and
24.4 ± 0.5 g (p < 0.05), 6.2 ± 0.2 mM (NS), and 0.94 ± 0.11 ng/ml (NS), respectively,
for mGPDH
/
mice (n = 11 in each group).
, and
/
mice. Total RNA of islets was
extracted using Isogen (Nippon Gene, Tokyo, Japan). The RNA (0.5 µg)
was reverse-transcribed and PCR amplified in a single reaction tube
catalyzed by a rTth DNA polymerase (Toyobo, Osaka, Japan). Two pairs of
primers, 5'-GCACTAAATTGATCCACGG-3' and
5'-ACGTAACTGCTCTTCAGGCATTG-3', 5'-TCCACCACCCTGTTGCTGTA-3' and
5'-ACCACAGTCCATGCCATCAC-3', were used for amplification of mGPDH
and glyceraldehyde-3-phosphate dehydrogenase gene transcripts, respectively. For detection of mGPDH protein by Western blot analysis, an anti-mGPDH antibody was raised against an oligopeptide
(KTAEENLDRRVPIPVDRSCGGL) corresponding to its carboxyl-terminal
sequence, and was affinity-purified. Islets were homogenized in 0.23 M mannitol, 0.07 M sucrose, and 5 mM potassium Hepes, pH 7.5, and electrophoresed in 10%
SDS-polyacrylamide gel. Proteins were transferred to nitrocellulose
membrane and the mGPDH signal was detected with an ECL system (Amersham
Pharmacia Biotech). To measure mGPDH enzymatic activity in islet
homogenates (300-500 islets per experiment)
2-p-iodo-3-p-nitro-5-phenyltetrazolium chloride
(Sigma) was used as an electron acceptor, as described previously
(31).
Cells--
One wild-type and one mGPDH
/
mouse were
usually killed on the same day. Their islets were isolated by
collagenase digestion of the pancreas, followed by hand-picking (32).
The medium used was a bicarbonate-buffered solution containing 120 mM NaCl, 4.8 mM KCl, 2.5 mM
CaCl2, 1.2 mM MgCl2, 24 mM NaHCO3, 10 mM glucose, and 1 mg/ml bovine serum albumin. It was gassed with
O2/CO2 to maintain a pH of 7.4. The islets were
then cultured for 1 or 2 days in RPMI 1640 medium containing 10 mM glucose, 10% heat-inactivated fetal bovine serum, 100 IU/ml penicillin, and 100 µg/ml streptomycin. To obtain clusters of
cells, some islets were incubated for 5 min in a Ca2+-free
medium. After brief centrifugation, this solution was replaced by
culture medium and the islets were disrupted by gentle pipetting through a siliconized glass pipette. The clusters were then cultured for 2 days on circular glass coverslips (33).
/
mice
(110 ± 7 ng/islet, n = 22).
/
(16 ± 1 cells) mice.
Cell Membrane Potential--
The membrane
potential of a single cell within an islet was measured with a high
resistance intracellular microelectrode (35). The only difference from
the described method was that a single isolated islet cultured for 1 or
2 days was used instead of a piece of pancreas.
Cells were
identified by the typical electrical activity that they display in the
presence of 10 mM glucose. The medium was the same as that
used for islet isolation but did not contain albumin.
/
mice. The results are illustrated by
representative traces and/or presented as means (± S.E.). The
statistical significance between means was assessed by unpaired or
paired Student's t test as appropriate, and that of
differences between percentages by Fisher's exact test. Differences
were considered significant at p < 0.05.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
islets (Fig.
1A, upper panel), whereas the
glyceraldehyde-3-phosphate dehydrogenase gene transcript was amplified
as effectively as that in wild-type islets (Fig. 1A, lower
panel). The absence of mGPDH in mGPDH
/
islets was
confirmed by Western blot analysis with anti-mGPDH antibody (Fig.
1B), and by an assay of the enzymatic activity in islets
homogenates (Fig. 1C). No mGPDH mRNA and protein was detected in muscle and liver tissues of mGPDH
/
mice.2 The mGPDH mRNA was
easily detectable in islets of heterozygous (mGPDH+/
)
mice, but the experimental conditions do not permit reliable quantification. The mGPDH protein and activity were decreased by about
40% in these heterozygous islets (Fig. 1).

View larger version (39K):
[in a new window]
Fig. 1.
Expression and activity of mGPDH in islets
from mGPDH+/+ (WT), mGPDH+/
(Hetero), and mGPDH
/
(Null) mice. A, RT-PCR analysis of
mGPDH mRNA. Two hundred ng of total RNA extracted from islets was
reverse-transcribed and amplified by 30 cycles of PCR (upper
panel). As controls, transcripts of glyceraldehyde-3-phosphate
dehydrogenase (G3PDH) gene were amplified by 25 cycles of
PCR (lower panel). B, Western blot analysis of
mGPDH protein. Homogenates (100 µg of protein) prepared from islets
were separated by SDS-polyacrylamide gel electrophoresis and blotted
with anti-mGPDH antibody. C, enzymatic activity of mGPDH in
islet homogenates (mean ± S.E.; four independent experiments with
triplicate batches).
/
mice.

View larger version (40K):
[in a new window]
Fig. 2.
Effects of glucose on cytoplasmic
[Ca2+]i in clusters of islet cells from wild-type
(mGPDH+/+) and mGPDH
/
mice. In the
experiments shown in the upper panels (A and
D), the concentration of glucose was raised from 3 to 15 mM as indicated. The lower panels show details
of [Ca2+]i oscillations recorded during
continuous stimulation with 15 mM glucose. All experiments
were performed with clusters cultured for 2 days. The traces are
representative of results obtained in 15 clusters from five different
mice.
/
mice (Fig. 2). The
frequency of the slow oscillations (0.25 ± 0.02 versus
0.27 ± 0.02 per min, respectively) and the average [Ca2+]i over 30 min of steady state stimulation
with 15 mM glucose (283 ± 16 versus
273 ± 16 nM, respectively) were also similar in the
two types of islets.
/
islets. The effect of AOA (used to inhibit the
malate-aspartate shuttle) was, however, very different. Six to 7 min
after addition of 5 mM AOA to the medium,
[Ca2+]i stopped to oscillate and returned to
close to basal values in all mGPDH
/
islets (Fig. 3,
C and D). In wild-type islets, AOA only had a weak inhibitory effect, characterized by a decrease in the frequency of
the oscillations. As shown in the inset of Fig.
3B, average [Ca2+]i slowly but
steadily increased with time in control islets continuously stimulated
with 15 mM glucose alone. In contrast, [Ca2+]i slightly decreased after addition of AOA
and averaged 190 ± 6 nM between 35 and 40 min, which
was significantly different (p < 0.001) from the
concentration measured in control islets without AOA (250 ± 5 nM) and in mGPDH
/
islets treated with AOA
(131 ± 6 nM).

View larger version (35K):
[in a new window]
Fig. 3.
Effects of glucose (G) and
AOA on cytoplasmic [Ca2+]i in intact islets from
wild-type (mGPDH+/+) and mGPDH
/
mice.
The concentration of glucose was raised from 3 to 15 mM,
and 5 mM AOA was added as indicated on top of
each panel. All experiments were performed with islets cultured for 1 day. The upper panels show individual experiments and the
lower panels show means (± S.E.) for 12 mGPDH
/
and 22 mGPDH+/+ islets from four to
six different mice. The inset in B shows average
[Ca2+]i (integrated over 5-min periods) in the
islets treated with AOA from 20 min (
) and in a group of 12 control
islets stimulated with glucose alone until the end of the experiment
(
). S.E. are of the symbol size.
/
islets (Fig.
4, C and D), with an incidence of 81 and 19%,
respectively. The frequency of the slow oscillations was 0.30 ± 0.01 and 0.31 ± 0.02 per min in wild-type and
mGPDH
/
islets, respectively.

View larger version (34K):
[in a new window]
Fig. 4.
Characteristics of cytoplasmic
[Ca2+]i oscillations induced by glucose and of
their modifications by AOA in intact islets from wild type
(mGDPH+/+) and mGPDH
/
mice. The
glucose concentration was 12 mM during the whole
experiments (40 min) and 1 mM AOA was added after 15 min.
All experiments were performed with islets cultured for 2 days. The
traces are representative of 13 mGPDH
/
and 22 mGPDH+/+ islets from four to six mice. Panel E
shows average [Ca2+]i (integrated over 5-min
periods) in the two groups of islets treated with AOA (
,
) and in
a group of 11 control islets stimulated with glucose alone until the
end of the experiment (dotted line).
/
islets with fast
oscillations, mixed oscillations appeared and then stopped (Fig.
4C). In some cases, the inhibition by AOA was preceded by a
transient phase of [Ca2+]i increase (Fig.
4D). We have no explanation for this phenomenon that was
also occasionally seen in wild-type islets (not shown). Fig.
4E shows that average [Ca2+]i was
similar in the two groups of islets during perifusion with 12 mM glucose alone. Upon addition of AOA,
[Ca2+]i decreased slightly in wild-type islets
(p < 0.01 versus untreated controls) and
considerably more in mGPDH
/
islets.
Cell Electrical
Activity--
In the presence of 3 mM glucose, the resting
potential of
cells was similar in wild-type (
64 ± 2 mV) and
mGPDH
/
islets (
66 ± 2 mV). Upon stimulation
with 12 mM glucose, the membrane depolarized to a plateau
potential with continuous spike activity (Fig.
5, A and C). The
membrane potential then started to oscillate with bursts of spikes on
top of each oscillation. During steady-state stimulation of wild-type
islets with 10 or 12 mM glucose, the oscillations of the
membrane potential were either regular and rapid (Fig. 5A),
or displayed a mixed pattern (Fig. 5B) (50% of each pattern
in 10 mM glucose n = 20) (Fig. 5A). Both
patterns were also seen in mGPDH
/
islets (46% regular
and 54% mixed in 10 mM glucose, n = 13), and could sometimes be observed in the same cell (Fig. 5, C
and D). The similarity of glucose-induced electrical
activity in both types of islets is consistent with the unaltered
properties of the K+-ATP channels in the
cell membrane
of mGPDH
/
mice (30).

View larger version (30K):
[in a new window]
Fig. 5.
Effects of glucose (G) and
AOA on the membrane potential of
cells within
intact islets from wild-type (mGPDH+/+) and
mGPDH
/
mice.
Cells were impaled with the
microelectrode during perifusion with a medium containing 10 mM glucose. When the electrical activity was stable, the
preparation was perifused with a medium containing 3 mM
glucose for 10 min. The glucose concentration was then raised to 12 mM and 5 mM AOA was added 15 min later. The
experiments were performed with islets cultured for 1 or 2 days.
Records A and B were obtained in different mice.
Records C and D show a continuous experiment
without interruption. Complete experiments of this type were performed
with 6 mGPDH
/
islets and 12 mGPDH+/+
islets. The mean electrical activity (calculated as % of time at
plateau with spikes) is shown in panel E, where the
dotted line corresponds to the mean electrical activity in 6 control islets stimulated with glucose alone until the end of the
experiment.
cell membrane in mGPDH
/
islets (Fig. 5D).
Fig. 5E is a quantification of the electrical activity
induced by glucose (percentage of time at plateau potential with
spikes) and of its inhibition by AOA. It first shows that glucose-induced electrical activity was quantitatively similar in the
two types of islets. It then shows that AOA only had a small inhibitory
effect in wild-type islets. After 15 min of AOA application, electrical
activity was still present during 45 ± 5% of the time
versus 67 ± 9% in control islets not treated with AOA
(p < 0.05). This contrasts with the abrogation of
electrical activity and the repolarization of
cells to a potential
(
61 ± 3 mV) close to the resting potential in
mGPDH
/
islets.
/
islets were perifused with a
medium containing 15 mM glucose; diazoxide (100 µM) was also added to prevent glucose from depolarizing the membrane (36) and raising [Ca2+]i (4).
Oscillations of [Ca2+]i were then imposed by
repetitive 2-min depolarizations with 30 mM K+
(Fig. 6). Each of these triggered a peak
of insulin secretion. The inactivation of mGPDH did not impair these
responses.

View larger version (53K):
[in a new window]
Fig. 6.
Effects of repetitive depolarizations with
high K+ on cytoplasmic [Ca2+]i and
insulin secretion measured simultaneously in single islets from wild
type (mGPDH+/+) and mGPDH
/
mice.
Single islets loaded with fura-PE3 were perifused with a medium
containing 15 mM glucose (G) and 0.1 mM diazoxide (Dz). The concentration of KCl was
increased from 4.8 to 30 mM (K30) for 2 min
every 4 min (shaded periods). The experiments were performed
with islets cultured for 1 day. The results are shown as mean values
for [Ca2+]i and insulin secretion changes
measured in 4 islets from different mice.

View larger version (87K):
[in a new window]
Fig. 7.
Effects of intermittent or sustained
stimulations with glucose on cytoplasmic [Ca2+]i
and insulin secretion measured simultaneously in single islets from
wild-type (mGPDH+/+) and mGPDH
/
mice.
The concentration of glucose (G) was increased from 3 to 20 mM for 2.5 min every 5 or for 25 min (shaded
periods). When indicated, 5 mM AOA was present
throughout the experiments. All experiments were performed with islets
cultured for 1 day. The upper panels show individual
experiments, the middle panels show means (±S.E.) for four
to five islets from different mice, and the lower panels
show details of the temporal correlations between mean
[Ca2+]i and insulin secretion changes.
/
mice were stimulated with 20 mM glucose alone, the [Ca2+]i and
insulin secretion responses were essentially similar to those observed
in wild-type islets (Fig. 7C). The situation was very
different in the presence of 5 mM AOA (Fig. 7D).
Raising the glucose concentration from 3 to 20 mM caused a
drop in [Ca2+]i, whereas the return to the
low-glucose medium was followed by an increase in
[Ca2+]i. This is most easily seen in the
lower panel of Fig. 7D. During sustained
stimulation with glucose, [Ca2+]i slightly
increased after the initial fall, but remained much lower than in the
absence of AOA. The upper panel of Fig. 7D
illustrates the largest response in an mGPDH
/
islet
treated with AOA. Under these conditions, insulin secretion was not
stimulated at all.
/
mice.

View larger version (19K):
[in a new window]
Fig. 8.
Effects of glucose and high K+ on
the NAD(P)H fluorescence of islets from wild-type
(mGPDH+/+) and mGPDH
/
mice. The medium
contained 0.1 mM diazoxide (Dz) throughout,
whereas the concentration of glucose (G) was raised from 3 to 15 mM at 15 min. The concentration of KCl was 4.8 mM except during the two 5-min periods of stimulation with
30 mM K+ (K30). The results are
expressed as a percentage of the fluorescence recorded at 3 mM glucose. The experiments were performed with islets
cultured for 2 days. Values are mean ± S.E. from 11 islets from
four different mice.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
than non-
cells (12, 15). This peculiar biochemical organization (high
mGPDH/lactate dehydrogenase ratio) is thought to be important for
optimal coupling of glucose metabolism by the
cell and insulin secretion. Observations of a decreased activity of mGPDH in islets from
type 2 diabetic patients and several animal models of the disease (11)
have lent support to this concept, although recent studies have
challenged the hypothesis (39, 40).
/
islets, and that the oscillatory
characteristics of the electrical, ionic, and secretory events induced
by glucose are similar in both types of islets. Since no mGPDH could be
detected immunologically or enzymatically in mGPDH
/
islets it appears that the malate-aspartate shuttle can compensate for
the absence of glycerol-phosphate shuttle in all these biological functions.
/
islets. It
has been reported that the rise in the ATP/ADP ratio that glucose
produces in
cells (43) of normal islets (34) is markedly attenuated
by AOA in mGPDH
/
islets (21). This reflects a major
alteration of glucose metabolism (21) and may explain why the
cell
membrane was no longer depolarized and Ca2+ influx,
manifested by the electrical activity, was no longer stimulated by
glucose. At variance with a previous report (21), [Ca2+]i remained low when mGPDH
/
islets were challenged with glucose in the presence of AOA. There was
thus no paradoxical dissociation between [Ca2+]i
and the suppression of insulin secretion. We, therefore, conclude that
the NADH shuttles play an important role in glucose-induced insulin
secretion and that the normal functioning of one of the two shuttles
can largely compensate for an impairment of the other. This at least
partial redundancy of the two NADH shuttles supports the importance of
the system for the
cell functioning.
cells. A number of events regularly
oscillate in
cells during stimulation with a constant concentration
of glucose. The origin of these oscillations is still incompletely
understood (27), but a subtle interplay between metabolic and
[Ca2+]i changes may be involved. In this respect,
the sensitivity of mGPDH to cytosolic [Ca2+]i
changes potentially confers a central position to the enzyme (28). The
present results, however, do not support this hypothesis. Thus, no
differences could be identified between glucose-induced oscillations of
cell membrane potential and [Ca2+]i in
wild-type and mGPDH
/
cells. The different phases of
the changes (initial fall, large increase and oscillations) and the
distinct patterns of the oscillations (regular fast or slow, and mixed
fast and slow) were all observed in both types of islets. Their
quantitative characteristics were also similar.
cell cytosolic
[Ca2+]i stimulates mitochondrial metabolism at
the levels of mGPDH and intramitochondrial dehydrogenases (13, 14, 18,
19, 44). This mechanism is viewed as a feed-forward process promoting ATP synthesis to sustain the secretory response. The present study, however, shows that repetitive stimulations with high glucose or high
K+ induced pulses of insulin secretion from
mGPDH
/
islets, which did not differ from the control
ones. No decrease in the response was observed, nor was there any
tendency to a fall during the second phase of insulin secretion induced
by sustained glucose stimulation. These results do not support the idea
that mGPDH is a critical site where changes in cytosolic
[Ca2+]i play a regulatory role in glucose
metabolism and subsequent functional events. Similar doubts have been
raised by studies of the effects of Ca2+ on ATP production
by islet mitochondria incubated with glycerol 3-phosphate (45). One
should also keep in mind that the increase in NAD(P)H fluorescence,
that follows glucose stimulation, is largely independent of an
intracellular [Ca2+]i rise (Fig. 7). In addition
and even more importantly, the increase in NAD(P)H fluorescence brought
about by Ca2+ in low or high glucose was not affected by
the inactivation of mGPDH. [Ca2+]i stimulation of
glucose metabolism through activation of intramitochondrial
dehydrogenases thus appears to be independent of the functioning of the
glycerol phosphate shuttle and its activation by
[Ca2+]i.
cells.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Wollheim, C. B.,
and Sharp, G. W. G.
(1981)
Physiol. Rev.
61,
914-973 2.
Prentki, M.,
and Matschinsky, F. M.
(1987)
Physiol. Rev.
67,
1185-1248 3.
Misler, S.,
Barnett, D. W.,
Gillis, K. D.,
and Pressel, D. M.
(1992)
Diabetes
41,
1221-1228[Abstract]
4.
Gilon, P.,
and Henquin, J. C.
(1992)
J. Biol. Chem.
267,
20713-20720 5.
Ashcroft, F. M.,
Proks, P.,
Smith, P. A.,
Ämmälä, C.,
Bokvist, K.,
and Rorsman, P.
(1994)
J. Cell. Biochem.
55S,
54-65
6.
Gembal, M.,
Gilon, P.,
and Henquin, J. C.
(1992)
J. Clin. Invest.
89,
1288-1295
7.
Gembal, M.,
Detimary, P.,
Gilon, P.,
Gao, Z. Y.,
and Henquin, J. C.
(1993)
J. Clin. Invest.
91,
871-880
8.
Sato, Y.,
Aizawa, T.,
Komatsu, M.,
Okada, N.,
and Yamada, T.
(1992)
Diabetes
41,
438-443[Abstract]
9.
Detimary, P.,
Gilon, P.,
Nenquin, M.,
and Henquin, J. C.
(1994)
Biochem. J.
297,
455-461
10.
Matschinsky, F. M.,
and Sweet, I. R.
(1996)
Diabetes Rev.
4,
130-144
11.
Malaisse, W. J.
(1996)
Diabetes Rev.
4,
145-159
12.
Schuit, F.,
De Vos, A.,
Farfari, S.,
Moens, K.,
Pipeleers, D.,
Brun, T.,
and Prentki, M.
(1997)
J. Biol. Chem.
272,
18572-18579 13.
Kennedy, E. D.,
and Wollheim, C. B.
(1998)
Diabetes Metab.
24,
15-24[Medline]
[Order article via Infotrieve]
14.
McCormack, J. G.,
Halestrap, A. P.,
and Denton, R. M.
(1990)
Physiol. Rev.
70,
391-425 15.
Sekine, N.,
Cirulli, V.,
Regazzi, R.,
Brown, L. J.,
Gine, E.,
Tamarit-Rodriguez, J.,
Girotti, M.,
Marie, S.,
MacDonald, M. J.,
Wollheim, C. B.,
and Rutter, G. A.
(1994)
J. Biol. Chem.
269,
4895-4902 16.
MacDonald, M. J.
(1981)
J. Biol. Chem.
256,
8287-8290 17.
MacDonald, M. J.
(1982)
Arch. Biochem. Biophys.
213,
643-649[CrossRef][Medline]
[Order article via Infotrieve]
18.
Rasschaert, J.,
and Malaisse, W. J.
(1991)
Biochem. J.
278,
335-340
19.
Rutter, G. A.,
Pralong, W. F.,
and Wollheim, C. B.
(1992)
Biochim. Biophys. Acta
1175,
107-113[Medline]
[Order article via Infotrieve]
20.
Dukes, I. D.,
McIntyre, M. S.,
Mertz, R. J.,
Philipson, L. H.,
Roe, M. W.,
Spencer, B.,
and Worley, J. F.
(1994)
J. Biol. Chem.
269,
10979-10982 21.
Eto, K.,
Tsubamoto, Y.,
Terauchi, Y.,
Sugiyama, T.,
Kishimoto, T.,
Takahashi, N.,
Yamauchi, N.,
Kubota, N.,
Murayama, S.,
Aizawa, T.,
Akanuma, Y.,
Aizawa, S.,
Kasai, H.,
Yazaki, Y.,
and Kadowaki, T.
(1999)
Science
283,
981-985 22.
Santos, R. M.,
Rosario, L. M.,
Nadal, A.,
Garcia-Sancho, J.,
Soria, B.,
and Valdeolmillos, M.
(1991)
Pflügers Arch.
418,
417-422[CrossRef][Medline]
[Order article via Infotrieve]
23.
Gilon, P.,
Shepherd, R. M.,
and Henquin, J. C.
(1993)
J. Biol. Chem.
268,
22265-22268 24.
Bergsten, P.,
Grapengiesser, E.,
Gylfe, E.,
Tengholm, A.,
and Hellman, B.
(1994)
J. Biol. Chem.
269,
8749-8753 25.
Barbosa, R. M.,
Silva, A. M.,
Tomé, A. R.,
Stamford, J. A.,
Santos, R. M.,
and Rosario, L. M.
(1998)
J. Physiol.
510,
135-143 26.
Cunningham, B. A.,
Deeney, J. T.,
Bliss, C. R.,
Corkey, B. E.,
and Tornheim, K.
(1996)
Am. J. Physiol.
271,
E702-E710 27.
Tornheim, K.
(1997)
Diabetes
46,
1375-1380[Abstract]
28.
MacDonald, M. J.,
Al-Masri, H.,
Jumelle-Laclau, M.,
and Cruz, M. O.
(1997)
Diabetes
46,
1996-2001[Abstract]
29.
Malaisse, W. J.,
Malaisse-Lagae, F.,
and Sener, A.
(1982)
Endocrinology
111,
392-397[Abstract]
30.
Eto, K.,
Suga, S.,
Wakui, M.,
Tsubamoto, Y.,
Terauchi, Y.,
Taka, J.,
Aizawa, S.,
Noda, M.,
Kimura, S.,
Kasai, H.,
and Kadowaki, T.
(1999)
J. Biol. Chem.
274,
25386-25392 31.
Gardner, R. S.
(1974)
Anal. Biochem.
59,
272-276[CrossRef][Medline]
[Order article via Infotrieve]
32.
Jonas, J. C.,
Gilon, P.,
and Henquin, J. C.
(1998)
Diabetes
47,
1266-1273[Abstract]
33.
Jonkers, F. C.,
Jonas, J. C.,
Gilon, P.,
and Henquin, J. C.
(1999)
J. Physiol.
520,
839-849 34.
Detimary, P.,
Jonas, J. C.,
and Henquin, J. C.
(1995)
J. Clin. Invest.
96,
1738-1745
35.
Meissner, H. P.
(1990)
Methods Enzymol.
192,
235-246[Medline]
[Order article via Infotrieve]
36.
Henquin, J. C.,
and Meissner, H. P.
(1982)
Biochem. Pharmacol.
31,
1407-1415[CrossRef][Medline]
[Order article via Infotrieve]
37.
Lenzen, S.
(1979)
Am. J. Physiol.
236,
E391-400 38.
Berglund, O.
(1980)
Acta Endocrinol.
93,
54-60
39.
MacDonald, M. J.,
Efendic, S.,
and Ostenson, C.-G.
(1996)
Diabetes
45,
886-890[Abstract]
40.
Ueda, K.,
Tanizawa, Y.,
Ishihara, H.,
Kizuki, N.,
Ohta, Y.,
Matsutani, A.,
and Oka, Y.
(1998)
Diabetologia
41,
649-653[CrossRef][Medline]
[Order article via Infotrieve]
41.
Berry, M. N.,
Gregory, R. B.,
Grivell, A. R.,
Phillips, J. W.,
and Schön, A.
(1994)
Eur. J. Biochem.
225,
557-564[Medline]
[Order article via Infotrieve]
42.
Barron, J. T.,
Gu, L.,
and Parrillo, J. E.
(1998)
J. Mol. Cell. Cardiol.
30,
1571-1579[CrossRef][Medline]
[Order article via Infotrieve]
43.
Detimary, P.,
Dejonghe, S.,
Ling, Z.,
Pipeleers, D.,
Schuit, F.,
and Henquin, J. C.
(1998)
J. Biol. Chem.
273,
33905-33908 44.
Civelek, V. N.,
Deeney, J. T.,
Shalosky, N. J.,
Tornheim, K.,
Hansford, R. G.,
Prentki, M.,
and Corkey, B. E.
(1996)
Biochem. J.
318,
615-621
45.
Idahl, L.-A.,
and Lembert, N.
(1995)
Biochem. J.
312,
287-292
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Bao, D. A. Jacobson, M. Wohltmann, A. Bohrer, W. Jin, L. H. Philipson, and J. Turk Glucose homeostasis, insulin secretion, and islet phospholipids in mice that overexpress iPLA2{beta} in pancreatic {beta}-cells and in iPLA2{beta}-null mice Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E217 - E229. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Baroukh, M. A. Ravier, M. K. Loder, E. V. Hill, A. Bounacer, R. Scharfmann, G. A. Rutter, and E. Van Obberghen MicroRNA-124a Regulates Foxa2 Expression and Intracellular Signaling in Pancreatic beta-Cell Lines J. Biol. Chem., July 6, 2007; 282(27): 19575 - 19588. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Satrustegui, B. Pardo, and A. del Arco Mitochondrial Transporters as Novel Targets for Intracellular Calcium Signaling Physiol Rev, January 1, 2007; 87(1): 29 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Manning Fox, A. V. Gyulkhandanyan, L. S. Satin, and M. B. Wheeler Oscillatory Membrane Potential Response to Glucose in Islet {beta}-Cells: A Comparison of Islet-Cell Electrical Activity in Mouse and Rat |